Parnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Standalone and Consolidated Un-audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parnax Lab Ltd has informed BSE that its Board of Directors will meet on Friday, 13 February 2026 at the registered office in Mumbai. The key agenda is to consider and approve the Standalone and Consolidated Un-audited IND-AS compliant financial results for Q3 (quarter ended 31 December 2025) and the nine-month period ending the same date, along with the Limited Review Report. The trading window for insiders has been closed since 1 January 2026 and will reopen 48 hours after the results are declared. No financial numbers or results are disclosed in this filing — only the meeting notice.
This is a routine procedural filing with no direct impact on the stock. Investors should watch for the actual Q3 results after 13 February 2026 for any meaningful performance insights.